Development of Oncolytic viruses as potential cancer therapeutics
gem0104
Member Posts: 1
I came across a very informative site that you all might be interested in. Please allow me to share it with you. It's the official website for Oncolytics Biotech, Inc. Oncolytics Biotech is a company focused on developing new treatments for cancer patients.
Oncolytics Biotech proprietary reovirus formulation, Reolysin, is active against approximately two thirds of all human cancers. The respiratory enteric orphan virus or reovirus, is a harmless virus that has shown powerful anti-cancer activity against cultured tumour cell. Check-out their site : http://www.oncolyticsbiotech.com/
Oncolytics Biotech proprietary reovirus formulation, Reolysin, is active against approximately two thirds of all human cancers. The respiratory enteric orphan virus or reovirus, is a harmless virus that has shown powerful anti-cancer activity against cultured tumour cell. Check-out their site : http://www.oncolyticsbiotech.com/
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 122K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 398 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 673 Leukemia
- 794 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 238 Multiple Myeloma
- 7.2K Ovarian Cancer
- 63 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 542 Sarcoma
- 736 Skin Cancer
- 656 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards